1. Role of Presenilin-1 in Aggressive Human Melanoma
   Julia Sidor et al, 2022, International Journal of Molecular Sciences CrossRef
2. Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum
   Cristina Fortuno et al, 2024, JCO Precision Oncology CrossRef
3. Genetic testing for familial melanoma
   Clare A. PRIMIERO et al, 2024, Italian Journal of Dermatology and Venereology CrossRef
4. Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis
   Rensen Ran et al, 2022, Molecular Oncology CrossRef
5. Management of cutaneous melanoma: radiologists challenging and risk assessment
   Vincenza Granata et al, 2022, La radiologia medica CrossRef
6. Genetic Testing for Successive Cancer Treatment
   Desh Nidhi Singh et al, 2023, Cureus CrossRef
7. TINF2 is a major susceptibility gene in Danish patients with multiple primary melanoma
   Marlene Richter Jensen et al, 2023, Human Genetics and Genomics Advances CrossRef